IndraLab
Statements
reach
"USP14 is a regulator of de‐ubiquitination and has been reported to be activated through AKT/mTOR pathway and negatively regulate autophagy by K48 de‐ubiquitination in neurodegenerative diseases.32 Hence, we speculated that SPAG5‐AS1 might regulate SPAG5 through USP14.RNA immunoprecipitation analysis confirmed that SPAG5‐AS1 was abundant in USP14‐binding complexes (Figure 6B)."
reach
"Considering that USP14 negatively regulates autophagy and positively drives NF-κB activation [31, 32], consistent with our observation, we tested the hypothesis in microglial BV2 cells by interfering Usp14 expression (Supplementary Fig. 4a and b; the second one was selected as the most efficient sequence)."
reach
"Together, it was suggested that SPAG5‐AS1 stabilized SPAG5 protein through interacting with USP14 in HG‐treated HPCs, and that USP14 and AKT/mTOR formed a positive feedback loop.3.7
SPAG5-AS1 promoted apoptosis and attenuated autophagy in HG-treated HPCs through SPAG5/AKT/mTOR pathway."
reach
"On the other hand, it is also possible that the IU1 induced neuroprotection in the post-ischemic mouse brains is a synergistic effect of multiple pathways activated by suppression of USP14 through IU1, since recent results suggest that inhibition of USP14 by IU1 in vitro elevates autophagy activity."
reach
"USP14 has been shown to negatively regulate autophagy, where USP14 KD or inhibition resulted in increased number of autophagy vesicles, autophagosomes, and autolysosomes, increased mitochondrial fragmentation, reduced mitochondrial volume, and increased association between the 20S proteasome and USP14 [84]."
reach
"Our data reveal that pharmacological inhibitor treatment of both ubh-4 and usp-14 suppresses autophagy at an early stage.In hypodermal seam cells, b-AP15 treatment did not affect the number of APs but resulted in more ALs (Fig. 6B) suggesting a faster fusion of APs with lysosomes or slow lysosomal degradation."
reach
"Additionally, an alternative mechanism for the inhibition of autophagy by USP14 has been suggested involving competitive binding of USP14 and Beclin 1 with tumor necrosis factor receptor-associated factor 6 (TRAF6), a downstream effector of the Toll-like receptor 4 (TLR4) signaling, which facilitates the K63-linked ubiquitination of Beclin-1."